Reports

Industry Research Reports

Biologic and Medical Imaging Reagents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Biologic and Medical Imaging Reagents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-18

Pages: 102 Pages

Report ld: 3434135

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Biologic and Medical Imaging Reagents Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

9.2%

marketSize

Market Size,2031

USD 46,350

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 27,340 million
Market Forecast in 2031(Value)
US$ 46,350 million
CAGR
9.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Biologic and Medical Imaging Reagents was estimated to be worth US$ 25250 million in 2024 and is forecast to a readjusted size of US$ 46350 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.

Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.

The global well-known brands in Biologic and Medical Imaging Reagents include Cardinal Health(6.77%), Bracco(5.41%), Bayer HealthCare(3.48%), Curium Pharma(2.02%), Hengrui Medicine(2.67%), GE Healthcare(2.53%), Lantheus Medical Imaging(2.01%), Novartis (AAA)(2.77%), Thermo Fisher Scientific(2.16%), Jubilant DraxImage(1.63%), PerkinElmer(1.44%), Guerbet(1.75%), Nihon Medi-Physics(1.75%), YRPG(1.09%) and Others(62.52%).

The application area of Biologic and Medical Imaging Reagents include Hospitals, Clinics and Other.

In terms of types, Biologic and Medical Imaging Reagents can be divided into Nuclear Imaging (PET & SPECT) Reagents, Magnetic Resonance Imaging (MRI) Reagents, Fluorescence Imaging Reagents, Ultrasound and X-ray Contrast Reagents and Other.

On basis of geography, Biologic and Medical Imaging Reagents are manufactured in North America, Europe, China and Japan.

This report aims to provide a comprehensive presentation of the global market for Biologic and Medical Imaging Reagents, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biologic and Medical Imaging Reagents by region & country, by Type, and by Application.

The Biologic and Medical Imaging Reagents market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic and Medical Imaging Reagents.

MARKET SEGMENTATION

By Company

  • Cardinal Health
  • Bracco
  • Bayer HealthCare
  • Curium Pharma
  • Hengrui Medicine
  • GE Healthcare
  • Lantheus Medical Imaging
  • Novartis (AAA)
  • Thermo Fisher Scientific
  • Jubilant DraxImage
  • PerkinElmer
  • Guerbet
  • Nihon Medi-Physics
  • YRPG

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Nuclear Imaging (PET & SPECT) Reagents
  • Magnetic Resonance Imaging (MRI) Reagents
  • Fluorescence Imaging Reagents
  • Ultrasound and X-ray Contrast Reagents
  • Other

Segment by Application

  • Hospitals
  • Clinics
  • Other

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 2: Detailed analysis of Biologic and Medical Imaging Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 5: Revenue of Biologic and Medical Imaging Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

marn_i1

Chapter 6: Revenue of Biologic and Medical Imaging Reagents in country level. It provides sigmate data by Type, and by Application for each country/region.

marn_i1

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

marn_i1

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Biologic and Medical Imaging Reagents Product Introduction

1.2 Global Biologic and Medical Imaging Reagents Market Size Forecast (2020-2031)

1.3 Biologic and Medical Imaging Reagents Market Trends & Drivers

1.3.1 Biologic and Medical Imaging Reagents Industry Trends

1.3.2 Biologic and Medical Imaging Reagents Market Drivers & Opportunity

1.3.3 Biologic and Medical Imaging Reagents Market Challenges

1.3.4 Biologic and Medical Imaging Reagents Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Competitive Analysis by Company

2.1 Global Biologic and Medical Imaging Reagents Players Revenue Ranking (2024)

2.2 Global Biologic and Medical Imaging Reagents Revenue by Company (2020-2025)

2.3 Key Companies Biologic and Medical Imaging Reagents Manufacturing Base Distribution and Headquarters

2.4 Key Companies Biologic and Medical Imaging Reagents Product Offered

2.5 Key Companies Time to Begin Mass Production of Biologic and Medical Imaging Reagents

2.6 Biologic and Medical Imaging Reagents Market Competitive Analysis

2.6.1 Biologic and Medical Imaging Reagents Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Biologic and Medical Imaging Reagents Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic and Medical Imaging Reagents as of 2024)

2.7 Mergers & Acquisitions, Expansion

muLu

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Nuclear Imaging (PET & SPECT) Reagents

3.1.2 Magnetic Resonance Imaging (MRI) Reagents

3.1.3 Fluorescence Imaging Reagents

3.1.4 Ultrasound and X-ray Contrast Reagents

3.1.5 Other

3.2 Global Biologic and Medical Imaging Reagents Sales Value by Type

3.2.1 Global Biologic and Medical Imaging Reagents Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Biologic and Medical Imaging Reagents Sales Value, by Type (2020-2031)

3.2.3 Global Biologic and Medical Imaging Reagents Sales Value, by Type (%) (2020-2031)

muLu

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Clinics

4.1.3 Other

4.2 Global Biologic and Medical Imaging Reagents Sales Value by Application

4.2.1 Global Biologic and Medical Imaging Reagents Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Biologic and Medical Imaging Reagents Sales Value, by Application (2020-2031)

4.2.3 Global Biologic and Medical Imaging Reagents Sales Value, by Application (%) (2020-2031)

muLu

5 Segmentation by Region

5.1 Global Biologic and Medical Imaging Reagents Sales Value by Region

5.1.1 Global Biologic and Medical Imaging Reagents Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Biologic and Medical Imaging Reagents Sales Value by Region (2020-2025)

5.1.3 Global Biologic and Medical Imaging Reagents Sales Value by Region (2026-2031)

5.1.4 Global Biologic and Medical Imaging Reagents Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Biologic and Medical Imaging Reagents Sales Value, 2020-2031

5.2.2 North America Biologic and Medical Imaging Reagents Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Biologic and Medical Imaging Reagents Sales Value, 2020-2031

5.3.2 Europe Biologic and Medical Imaging Reagents Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Biologic and Medical Imaging Reagents Sales Value, 2020-2031

5.4.2 Asia Pacific Biologic and Medical Imaging Reagents Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Biologic and Medical Imaging Reagents Sales Value, 2020-2031

5.5.2 South America Biologic and Medical Imaging Reagents Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Biologic and Medical Imaging Reagents Sales Value, 2020-2031

5.6.2 Middle East & Africa Biologic and Medical Imaging Reagents Sales Value by Country (%), 2024 VS 2031

muLu

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Biologic and Medical Imaging Reagents Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Biologic and Medical Imaging Reagents Sales Value, 2020-2031

6.3 United States

6.3.1 United States Biologic and Medical Imaging Reagents Sales Value, 2020-2031

6.3.2 United States Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Biologic and Medical Imaging Reagents Sales Value, 2020-2031

6.4.2 Europe Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Biologic and Medical Imaging Reagents Sales Value, 2020-2031

6.5.2 China Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031

6.5.3 China Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Biologic and Medical Imaging Reagents Sales Value, 2020-2031

6.6.2 Japan Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Biologic and Medical Imaging Reagents Sales Value, 2020-2031

6.7.2 South Korea Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Biologic and Medical Imaging Reagents Sales Value, 2020-2031

6.8.2 Southeast Asia Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Biologic and Medical Imaging Reagents Sales Value, 2020-2031

6.9.2 India Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031

6.9.3 India Biologic and Medical Imaging Reagents Sales Value by Application, 2024 VS 2031

muLu

7 Company Profiles

7.1 Cardinal Health

7.1.1 Cardinal Health Profile

7.1.2 Cardinal Health Main Business

7.1.3 Cardinal Health Biologic and Medical Imaging Reagents Products, Services and Solutions

7.1.4 Cardinal Health Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.1.5 Cardinal Health Recent Developments

7.2 Bracco

7.2.1 Bracco Profile

7.2.2 Bracco Main Business

7.2.3 Bracco Biologic and Medical Imaging Reagents Products, Services and Solutions

7.2.4 Bracco Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.2.5 Bracco Recent Developments

7.3 Bayer HealthCare

7.3.1 Bayer HealthCare Profile

7.3.2 Bayer HealthCare Main Business

7.3.3 Bayer HealthCare Biologic and Medical Imaging Reagents Products, Services and Solutions

7.3.4 Bayer HealthCare Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.3.5 Bayer HealthCare Recent Developments

7.4 Curium Pharma

7.4.1 Curium Pharma Profile

7.4.2 Curium Pharma Main Business

7.4.3 Curium Pharma Biologic and Medical Imaging Reagents Products, Services and Solutions

7.4.4 Curium Pharma Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.4.5 Curium Pharma Recent Developments

7.5 Hengrui Medicine

7.5.1 Hengrui Medicine Profile

7.5.2 Hengrui Medicine Main Business

7.5.3 Hengrui Medicine Biologic and Medical Imaging Reagents Products, Services and Solutions

7.5.4 Hengrui Medicine Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.5.5 Hengrui Medicine Recent Developments

7.6 GE Healthcare

7.6.1 GE Healthcare Profile

7.6.2 GE Healthcare Main Business

7.6.3 GE Healthcare Biologic and Medical Imaging Reagents Products, Services and Solutions

7.6.4 GE Healthcare Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.6.5 GE Healthcare Recent Developments

7.7 Lantheus Medical Imaging

7.7.1 Lantheus Medical Imaging Profile

7.7.2 Lantheus Medical Imaging Main Business

7.7.3 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Products, Services and Solutions

7.7.4 Lantheus Medical Imaging Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.7.5 Lantheus Medical Imaging Recent Developments

7.8 Novartis (AAA)

7.8.1 Novartis (AAA) Profile

7.8.2 Novartis (AAA) Main Business

7.8.3 Novartis (AAA) Biologic and Medical Imaging Reagents Products, Services and Solutions

7.8.4 Novartis (AAA) Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.8.5 Novartis (AAA) Recent Developments

7.9 Thermo Fisher Scientific

7.9.1 Thermo Fisher Scientific Profile

7.9.2 Thermo Fisher Scientific Main Business

7.9.3 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Products, Services and Solutions

7.9.4 Thermo Fisher Scientific Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.9.5 Thermo Fisher Scientific Recent Developments

7.10 Jubilant DraxImage

7.10.1 Jubilant DraxImage Profile

7.10.2 Jubilant DraxImage Main Business

7.10.3 Jubilant DraxImage Biologic and Medical Imaging Reagents Products, Services and Solutions

7.10.4 Jubilant DraxImage Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.10.5 Jubilant DraxImage Recent Developments

7.11 PerkinElmer

7.11.1 PerkinElmer Profile

7.11.2 PerkinElmer Main Business

7.11.3 PerkinElmer Biologic and Medical Imaging Reagents Products, Services and Solutions

7.11.4 PerkinElmer Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.11.5 PerkinElmer Recent Developments

7.12 Guerbet

7.12.1 Guerbet Profile

7.12.2 Guerbet Main Business

7.12.3 Guerbet Biologic and Medical Imaging Reagents Products, Services and Solutions

7.12.4 Guerbet Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.12.5 Guerbet Recent Developments

7.13 Nihon Medi-Physics

7.13.1 Nihon Medi-Physics Profile

7.13.2 Nihon Medi-Physics Main Business

7.13.3 Nihon Medi-Physics Biologic and Medical Imaging Reagents Products, Services and Solutions

7.13.4 Nihon Medi-Physics Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.13.5 Nihon Medi-Physics Recent Developments

7.14 YRPG

7.14.1 YRPG Profile

7.14.2 YRPG Main Business

7.14.3 YRPG Biologic and Medical Imaging Reagents Products, Services and Solutions

7.14.4 YRPG Biologic and Medical Imaging Reagents Revenue (US$ Million) & (2020-2025)

7.14.5 YRPG Recent Developments

muLu

8 Industry Chain Analysis

8.1 Biologic and Medical Imaging Reagents Industrial Chain

8.2 Biologic and Medical Imaging Reagents Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Biologic and Medical Imaging Reagents Sales Model

8.5.2 Sales Channel

8.5.3 Biologic and Medical Imaging Reagents Distributors

muLu

9 Research Findings and Conclusion

muLu

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Biologic and Medical Imaging Reagents Market Trends
Table 2. Biologic and Medical Imaging Reagents Market Drivers & Opportunity
Table 3. Biologic and Medical Imaging Reagents Market Challenges
Table 4. Biologic and Medical Imaging Reagents Market Restraints
Table 5. Global Biologic and Medical Imaging Reagents Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Biologic and Medical Imaging Reagents Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Biologic and Medical Imaging Reagents Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Biologic and Medical Imaging Reagents Product Type
Table 9. Key Companies Time to Begin Mass Production of Biologic and Medical Imaging Reagents
Table 10. Global Biologic and Medical Imaging Reagents Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic and Medical Imaging Reagents as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Biologic and Medical Imaging Reagents Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Biologic and Medical Imaging Reagents Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Biologic and Medical Imaging Reagents Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Biologic and Medical Imaging Reagents Sales Market Share in Value by Type (2020-2025)
Table 17. Global Biologic and Medical Imaging Reagents Sales Market Share in Value by Type (2026-2031)
Table 18. Global Biologic and Medical Imaging Reagents Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Biologic and Medical Imaging Reagents Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Biologic and Medical Imaging Reagents Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Biologic and Medical Imaging Reagents Sales Market Share in Value by Application (2020-2025)
Table 22. Global Biologic and Medical Imaging Reagents Sales Market Share in Value by Application (2026-2031)
Table 23. Global Biologic and Medical Imaging Reagents Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Biologic and Medical Imaging Reagents Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Biologic and Medical Imaging Reagents Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Biologic and Medical Imaging Reagents Sales Value by Region (2020-2025) & (%)
Table 27. Global Biologic and Medical Imaging Reagents Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Biologic and Medical Imaging Reagents Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Biologic and Medical Imaging Reagents Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Biologic and Medical Imaging Reagents Sales Value, (2026-2031) & (US$ Million)
Table 31. Cardinal Health Basic Information List
Table 32. Cardinal Health Description and Business Overview
Table 33. Cardinal Health Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 34. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of Cardinal Health (2020-2025)
Table 35. Cardinal Health Recent Developments
Table 36. Bracco Basic Information List
Table 37. Bracco Description and Business Overview
Table 38. Bracco Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 39. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of Bracco (2020-2025)
Table 40. Bracco Recent Developments
Table 41. Bayer HealthCare Basic Information List
Table 42. Bayer HealthCare Description and Business Overview
Table 43. Bayer HealthCare Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 44. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of Bayer HealthCare (2020-2025)
Table 45. Bayer HealthCare Recent Developments
Table 46. Curium Pharma Basic Information List
Table 47. Curium Pharma Description and Business Overview
Table 48. Curium Pharma Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 49. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of Curium Pharma (2020-2025)
Table 50. Curium Pharma Recent Developments
Table 51. Hengrui Medicine Basic Information List
Table 52. Hengrui Medicine Description and Business Overview
Table 53. Hengrui Medicine Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 54. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of Hengrui Medicine (2020-2025)
Table 55. Hengrui Medicine Recent Developments
Table 56. GE Healthcare Basic Information List
Table 57. GE Healthcare Description and Business Overview
Table 58. GE Healthcare Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 59. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of GE Healthcare (2020-2025)
Table 60. GE Healthcare Recent Developments
Table 61. Lantheus Medical Imaging Basic Information List
Table 62. Lantheus Medical Imaging Description and Business Overview
Table 63. Lantheus Medical Imaging Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 64. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of Lantheus Medical Imaging (2020-2025)
Table 65. Lantheus Medical Imaging Recent Developments
Table 66. Novartis (AAA) Basic Information List
Table 67. Novartis (AAA) Description and Business Overview
Table 68. Novartis (AAA) Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 69. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of Novartis (AAA) (2020-2025)
Table 70. Novartis (AAA) Recent Developments
Table 71. Thermo Fisher Scientific Basic Information List
Table 72. Thermo Fisher Scientific Description and Business Overview
Table 73. Thermo Fisher Scientific Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 74. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of Thermo Fisher Scientific (2020-2025)
Table 75. Thermo Fisher Scientific Recent Developments
Table 76. Jubilant DraxImage Basic Information List
Table 77. Jubilant DraxImage Description and Business Overview
Table 78. Jubilant DraxImage Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 79. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of Jubilant DraxImage (2020-2025)
Table 80. Jubilant DraxImage Recent Developments
Table 81. PerkinElmer Basic Information List
Table 82. PerkinElmer Description and Business Overview
Table 83. PerkinElmer Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 84. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of PerkinElmer (2020-2025)
Table 85. PerkinElmer Recent Developments
Table 86. Guerbet Basic Information List
Table 87. Guerbet Description and Business Overview
Table 88. Guerbet Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 89. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of Guerbet (2020-2025)
Table 90. Guerbet Recent Developments
Table 91. Nihon Medi-Physics Basic Information List
Table 92. Nihon Medi-Physics Description and Business Overview
Table 93. Nihon Medi-Physics Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 94. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of Nihon Medi-Physics (2020-2025)
Table 95. Nihon Medi-Physics Recent Developments
Table 96. YRPG Basic Information List
Table 97. YRPG Description and Business Overview
Table 98. YRPG Biologic and Medical Imaging Reagents Products, Services and Solutions
Table 99. Revenue (US$ Million) in Biologic and Medical Imaging Reagents Business of YRPG (2020-2025)
Table 100. YRPG Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Biologic and Medical Imaging Reagents Downstream Customers
Table 104. Biologic and Medical Imaging Reagents Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
muLu

List of Figures

Figure 1. Biologic and Medical Imaging Reagents Product Picture
Figure 2. Global Biologic and Medical Imaging Reagents Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Biologic and Medical Imaging Reagents Sales Value (2020-2031) & (US$ Million)
Figure 4. Biologic and Medical Imaging Reagents Report Years Considered
Figure 5. Global Biologic and Medical Imaging Reagents Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Biologic and Medical Imaging Reagents Revenue in 2024
Figure 7. Biologic and Medical Imaging Reagents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Nuclear Imaging (PET & SPECT) Reagents Picture
Figure 9. Magnetic Resonance Imaging (MRI) Reagents Picture
Figure 10. Fluorescence Imaging Reagents Picture
Figure 11. Ultrasound and X-ray Contrast Reagents Picture
Figure 12. Other Picture
Figure 13. Global Biologic and Medical Imaging Reagents Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Biologic and Medical Imaging Reagents Sales Value Market Share by Type, 2024 & 2031
Figure 15. Product Picture of Hospitals
Figure 16. Product Picture of Clinics
Figure 17. Product Picture of Other
Figure 18. Global Biologic and Medical Imaging Reagents Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 19. Global Biologic and Medical Imaging Reagents Sales Value Market Share by Application, 2024 & 2031
Figure 20. North America Biologic and Medical Imaging Reagents Sales Value (2020-2031) & (US$ Million)
Figure 21. North America Biologic and Medical Imaging Reagents Sales Value by Country (%), 2024 VS 2031
Figure 22. Europe Biologic and Medical Imaging Reagents Sales Value, (2020-2031) & (US$ Million)
Figure 23. Europe Biologic and Medical Imaging Reagents Sales Value by Country (%), 2024 VS 2031
Figure 24. Asia Pacific Biologic and Medical Imaging Reagents Sales Value, (2020-2031) & (US$ Million)
Figure 25. Asia Pacific Biologic and Medical Imaging Reagents Sales Value by Region (%), 2024 VS 2031
Figure 26. South America Biologic and Medical Imaging Reagents Sales Value, (2020-2031) & (US$ Million)
Figure 27. South America Biologic and Medical Imaging Reagents Sales Value by Country (%), 2024 VS 2031
Figure 28. Middle East & Africa Biologic and Medical Imaging Reagents Sales Value, (2020-2031) & (US$ Million)
Figure 29. Middle East & Africa Biologic and Medical Imaging Reagents Sales Value by Country (%), 2024 VS 2031
Figure 30. Key Countries/Regions Biologic and Medical Imaging Reagents Sales Value (%), (2020-2031)
Figure 31. United States Biologic and Medical Imaging Reagents Sales Value, (2020-2031) & (US$ Million)
Figure 32. United States Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
Figure 33. United States Biologic and Medical Imaging Reagents Sales Value by Application (%), 2024 VS 2031
Figure 34. Europe Biologic and Medical Imaging Reagents Sales Value, (2020-2031) & (US$ Million)
Figure 35. Europe Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
Figure 36. Europe Biologic and Medical Imaging Reagents Sales Value by Application (%), 2024 VS 2031
Figure 37. China Biologic and Medical Imaging Reagents Sales Value, (2020-2031) & (US$ Million)
Figure 38. China Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
Figure 39. China Biologic and Medical Imaging Reagents Sales Value by Application (%), 2024 VS 2031
Figure 40. Japan Biologic and Medical Imaging Reagents Sales Value, (2020-2031) & (US$ Million)
Figure 41. Japan Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
Figure 42. Japan Biologic and Medical Imaging Reagents Sales Value by Application (%), 2024 VS 2031
Figure 43. South Korea Biologic and Medical Imaging Reagents Sales Value, (2020-2031) & (US$ Million)
Figure 44. South Korea Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
Figure 45. South Korea Biologic and Medical Imaging Reagents Sales Value by Application (%), 2024 VS 2031
Figure 46. Southeast Asia Biologic and Medical Imaging Reagents Sales Value, (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
Figure 48. Southeast Asia Biologic and Medical Imaging Reagents Sales Value by Application (%), 2024 VS 2031
Figure 49. India Biologic and Medical Imaging Reagents Sales Value, (2020-2031) & (US$ Million)
Figure 50. India Biologic and Medical Imaging Reagents Sales Value by Type (%), 2024 VS 2031
Figure 51. India Biologic and Medical Imaging Reagents Sales Value by Application (%), 2024 VS 2031
Figure 52. Biologic and Medical Imaging Reagents Industrial Chain
Figure 53. Biologic and Medical Imaging Reagents Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Biologic and Medical Imaging Reagents in 2031?zhanKai
The global market size of Biologic and Medical Imaging Reagents in 2031 was 46350 Million USD.
Which region is expected to have the highest market share?shouQi
What is the annual compound growth rate of the global Biologic and Medical Imaging Reagents market size from 2025 to 2031?shouQi
What was the global market size of Biologic and Medical Imaging Reagents in 2025?shouQi
Which companies rank high in the global Biologic and Medical Imaging Reagents market?shouQi
den_biaoTiZhungShi

Related Reports

Biologic and Medical Imaging Reagents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-18

Pages: 102 Pages

Report ld: 3434135

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now